Literatur
- 1
Anscher M S, Samulski T V, Dodge R, Prosnitz L R, Dewhirst M W.
Combined external beam irradiation and external regional hyperthermia for locally
advanced adenocarcinoma of the prostate.
Int J Radiat Oncol Biol Phys.
1997;
37
1059-1065
- 2
Berdov B A, Menteshashvili G Z.
Thermoradiotherapy of patients with locally advanced carcinoma of the rectum.
Int J Hyperthermia.
1990;
6
881-890
- 3
Datta N R, Bose A K, Kapoor H K. et al .
Head and neck cancers: results of thermoradiotherapy versus rediotherapy.
Int J Hyperthermia.
1990;
6
479-486
- 4
Feyerabend T, Steeves R, Jäger B, Wiedemann G J, Sommer K, Richter E, Katschinski D M,
Robins H I.
Local hyperthermia, hyperfractionated radiation, and cisplatin in preirradiated recurrent
lymph node metastases of recurrent head and neck cancer.
Int J Oncol.
1997;
10
591-595
- 5
Harima Y, Nagata K, Harinma K. et al .
A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage
III cervical carcinoma.
Int J Hyperthermia.
2001;
17
97-105
- 6
Hegewisch-Becker S, Gruber Y, Corovic A, Pichlmeier U, Atanachovic D, Nierhaus A,
Hossfeld D K.
Whole-body hyperthermia (41.8 × C) combined with bimonthly oxaliplatin, high-dose
leucovorin and 5-fluorouracil 48-hr. continuous infusion in pretreated metastatic
colorectal cancer: a phase II study.
Ann Oncol.
2002;
13
1197-1204
- 7
Hehr T, Lamprecht U, Glocker S, Classen J, Paulsen F, Budach W, Bamberg M.
Thermoradiotherapy for locally recurrent breast cancer with skin involvement.
Int J Hyperthermia.
2001;
17
291-301
- 8
Hehr T, Wust P, Bamberg M, Budach W.
The current and potential role of thermotherapy for solid tumors.
Onkologie.
2003;
26
295-302
- 9 Hildebrandt B, Riess H, Dräger J, Kerner T, Felix R, Wust P. Whole-Body Hyperthermia
enhances the effectiveness of first line line therapy with Folinic Acid, 5-Fluorouracil,
and Mitomycin in patients with metastatic colorectal cancer - A phase I/II trial. Int
J Hyperthermia 2003: in press
- 10
Huang Q, Hu J K, Lohr F, Zhang L, Braun R, Lanzen J, Little J B, Dewhirst M W, Li C Y.
Heat- induced gene expression as a novel targeted cancer therapy strategy.
Cancer Res.
2000;
60
3435-3439
- 11
Issels R D, Prenninger S W, Nagele A, Boehm E, Sauer H, Jauch K W, Denecke H, Berger H,
Peter K, Wilmanns W.
lfosfamide plus etoposide combined with regional hyperthermia in patients with locally
advanced sarcomas: a phase II study.
J Clin Oncol.
1990;
8
1818-1829
- 12
Issels R D.
Hyperthermia combined with chemotherapy - biological rationale, clinical application
and treatment results.
Onkologie.
1999;
22
374-381
- 13
Issels R, Abdel-Rahman S, Wendtner C M, Falk M H, Kurze V, Sauer H, Aydemir U, Hiddemann W.
Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced
primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term
results of a phase II study.
Eur J Cancer.
2001;
37
1599-1608
- 14
Jordan A, Scholz R, Maier-Hauff K, Johannsen M, Wust P, Nadobny J, Schirra H, Schmidt H,
Deger S, Loening S, Lanksch W, Felix R.
Presentation of a new magnetic field therapy system for the treatment of human solid
tumors with magnetic fluid hyperthermia.
J Magnetism Magnetic Materials.
2001;
225
118-126
- 15
Kerner T, Hildebrandt B, Ahlers O, Deja M, Riess H, Draeger J, Wust P, Gerlach H.
Anesthesiological experiences with whole body hyperthermia.
Int J Hyperthermia.
2003;
19
1-12
- 16
Kitamura K, Kuwano H, Watanabe M. et al .
Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal
carcinoma.
J Surg Oncol.
1995;
60
55-58
- 17
Lagendijk J, van Rhoon G, Hornsleth S, Wust P, de Leeuw A, van Dijk J, van der Zee J,
van Heek R, Rahman S, Schneider C, Gromoll C.
ESHO quality assurance guidelines for regional hyperthermia.
Int J Hyperthermia.
1998;
14
125-133
- 18 Milani V, Noessner E, Ghose S, Kuppner M, Ahrens B, Scharner A, Gastpar R, Issels R D.
Heat shock protein 70 - role in antigen presentation and immune stimulation. Int J
Hyperthermia 2003: in press
- 19
Multhoff G, Botzler C, Jennen L, Schmidt J, Ellwart J, Issels R D.
Heat shock protein 72 on tumor cells - a recognition structure for Natural Killer
Cells.
J Immunol.
1997;
158
4341-4350
- 20
Overgaard J, Gonzalez-Gonzalez D, Hulshof M C, ArcangeliG , Dahl O, Mella O, Bentzen S M.
Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic
malignant melanoma.
Lancet.
1995;
345
540-543
- 21
Peller M, Löffler R, Baur A. et al .
MRT-gesteuerte regionale Tiefenhyperthermie.
Radiologe.
1999;
39
756-763
- 22
Peller M, Reinl H M, Weigel A, Meininger M, Issels R D, Reiser M.
T1-relaxation time at 0.2 Tesla for monitoring regional hyperthermia: feasibility
study in muscle and adipose tissue.
Magn Res Med.
2002;
47
1194-1201
- 23
Perez C A, Pajak T, Emami B. et al .
Randomized phase III study comparing irradiation and hyperthermia with irradiation
alone in superficial measurable tumors. Final report by the Radiation Therapy Oncology
Group.
Am J Clin Oncol.
1991;
14
133-141
- 24
Rau B, Wust P, Tilly W. et al .
Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional
radiofrequency hyperthermia correlates with clinical parameters.
Int J Radiat Oncol Biol Phys.
2000;
48
381-391
- 25
Schneider D T, Wessalowski R, Calaminus G, Pape H, Bamberg M, Engert J, Waag K, Gadner H,
Gobel U.
Treatment of recurrent malignant sacrococcygeal germ cell tumors: analysis of 22 patients
registered in the German protocols MAKEI 83/86, 89, and 96.
Clin Oncol.
2001;
19
1951-1960
- 26
Seebass M, Beck R, Gellermann J, Nadobny J, Wust P.
Electromagnetic phased arrays for regional hypertheramia - optimal frequency and antenna
arrangement.
Int J Hyperthermia.
2001;
17
321-336
- 27
Sneed P K, Stauffer P R, McDermott M W. et al .
Survival benefit of hyperthermia in a prospective randomised trial of brachytherapy
boost +/- hyperthermia for glioblastoma multiforme.
Int J Radiat Oncol Biol Phys.
1998;
40
287-295
- 28
Srivastava P.
Interaction of heat shock proteins with peptides and antigen presenting cells: Chaperoning
of the innate and adaptive immune responses.
Annu Rev Immunol.
2002;
20
395-425
- 29
Sugimachi K, Kuwano H, Ide H. et al .
Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma:
a prospective randomized trial.
Int J Hyperthermia.
1994;
10
485-493
- 30
Valdagni R, Amichetti M.
Report of a long-term follow-up in a randomized trial comparing radiation therapy
and radiation plus hyperthermia to metastatic lymph nodes in stage IV head and neck
cancer patients.
Int J Radiat Oncol Biol Phys.
1993;
28
163-169
- 31
van der Zee J, Gonzalez G onzales, van Rhoon G C. et al .
Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced
pelvic tumors: a prospective, randomised, multicentre trial.
Lancet.
2000;
355
1119-1125
- 32
Vernon C, Hand J W, Field S B. et al .
Radiotherapy with or without hyperthermia in the treatment of superficial localized
breast cancer: results from five randomized controlled trials.
Int J Radiat Oncol Biol Phys.
1996;
35
731-744
- 33
Walther W, Stein U, Schlag P M.
The utilization of heat inducibility of the human mdr1 promoter for cancer therapy.
Proc Amer Assoc Cancer Res.
1999;
40
477
- 34
Wells A D, Malkovsky M.
Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated
view.
Immunol Today.
2000;
21
129-132
- 35
Wendtner C M, Abdel-Rahman S, Baumert J, Falk M H, Krych M, Santl M, Hiddemann W,
Issels R D.
Treatment of primary, recurrent or inadequately resected high-risk soft tissue sarcomas
(HR-STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy
combined with regional hyperthermia.
Eur J Cancer.
2001;
37
1609-1616
- 36
Wendtner C M, Abdel-Rahman S, Krych M, Baumert J, Lindner L H, Baur A, Hiddemann W,
Issels R D.
Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts
long-term survival for adult patients with retroperitoneal and visceral high-risk
soft tissue sarcomas.
J Clin Oncol.
2002;
20
3156-3164
- 37
Wessalowski R, Kruck H, Pape H, Kahn T, Willers R, Gobel U.
Hyperthermia for the treatment of patients with malignant germ cell tumors: a phase
I/II study in ten children and adolescents with recurrent or refractory tumors.
Cancer.
1998;
15
793-800
- 38
Wust P, Stahl H, Dieckmann K, Scheller S, Löffel J, Riess H, Jahnke V, Bier J, Felix R.
Local hyperthermia of N2/N3 cervical lymphnode metastases: correlation of technical/
thermal parameters and response.
Int J Radiat Oncol Biol Phys.
1996;
34
635-646
- 39
Wust P, Gellermann J, Harder C, Tilly W, Rau B, Dinges S, Schlag P, Budach V, Felix R.
Rationale for using invasive thermometry for regional hyperthermia of pelvic tumors.
Int J Radiat Oncol Biol Phys.
1998;
41
1129-1137
- 40
Wust P, Riess H, Hildebrandt B, Löffel J, Deja M, Ahlers O, Kerner T, Wehner H, v .
Ardenne A, Felix R. Feasibility and analysis of thermal parameters for the whole body
hyperthermia system IRATHERM-2000.
Int J Hyperthermia.
2000;
16
325-339
- 41
Wust P, Fähling H, Wlodarczyk W, Seebass M, Gellermann J, Deuflhard P, Nadobny J.
Antenna arrays in the SIGMA-Eye applicator: Interactions and transforming networks.
Med Phys.
2001;
28
1793-1805
- 42
Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag P M.
Hyperthermia in a combined treatment of cancer.
The Lancet Oncology.
2002;
3
487-497
- 43 Wust P, Gellermann J, Seebass M, Fähling H, Turner P, Wlodarczyk W, Nadobny J,
Oppelt A, Schlag P M, Felix R. Teilkörperhyperthermie mit einem Radiofrequenz-Multiantennen-Applikator
unter on-line Kontrolle in einem 1,5 T MR-Tomographen. Röntg Fortschr 2003: in press
Prof. Dr. P. Wust
Klinik für Strahlentherapie, Charité - Campus Virchow-Klinikum
Augustenburger Platz 1
13353 Berlin
eMail: peter.wust@charite.de
